About the Authors
- Kentaro Sakamoto
-
Affiliation Toho University Ohashi Medical Center, Department of Diabetes and Metabolism, Tokyo, Japan
- Mitsunobu Kawamura
-
Affiliation Tokyo Teishin Hospital, Division of Endocrinology and Metabolism Department of Internal Medicine, Tokyo, Japan
- Takahide Kohro
-
Affiliation Jichi Medical University, Department of Medical Informatics / Cardiology, Tochigi, Japan
- Masao Omura
-
Affiliation Yokohama Rosai Hospital, Department of Endocrinology and Metabolism, Kanagawa, Japan
- Takayuki Watanabe
-
Affiliation Yokohama City Minato Red Cross Hospital, Department of Internal Medicine, Kanagawa, Japan
- Keiko Ashidate
-
Affiliation Kudanzaka Hospital, Department of Internal Medicine, Tokyo, Japan
- Toshiyuki Horiuchi
-
Affiliation Tokyo Metropolitan Health Medical Treatment Corporation Toshima Hospital, Department of Endocrinology and Metabolism, Tokyo, Japan
- Hidehiko Hara
-
Affiliation Toho University Ohashi Medical Center, Department of Cardiology, Tokyo, Japan
- Nobuo Sekine
-
Affiliation Tokyo Koseinenkin Hospital, Department of Internal Medicine, Tokyo, Japan
- Rina Chin
-
Affiliation Tokyo Kyosai Hospital, Department of Internal Medicine, Tokyo, Japan
- Motoyoshi Tsujino
-
Affiliation Tokyo Metropolitan Tama Medical Center, Department of Internal Medicine, Tokyo, Japan
- Toru Hiyoshi
-
Affiliation Japanese Red Cross Medical Center, Tokyo, Japan
- Motoki Tagami
-
Affiliation Sanraku Hospital, Life-style related Disease Clinic, Tokyo, Japan
- Akira Tanaka
-
Affiliation Kagawa Nutrition University, Nutrition Clinic, Tokyo, Japan
- Yasumichi Mori
-
Affiliation Toranomon Hospital, Department of Endocrinology and Metabolism, Tokyo, Japan
- Takeshi Inazawa
-
Affiliation Kashiwa City Hospital, Internal Medicine, Chiba, Japan
- Tsutomu Hirano
-
Affiliation Showa University School of Medicine, Department of Medicine Division of Diabetes Metabolism and Endocrinology, Tokyo, Japan
- Tsutomu Yamazaki
-
Affiliation The University of Tokyo Hospital, Clinical Research Support Center, Tokyo, Japan
- Teruo Shiba
-
* E-mail: teruo.shiba@med.toho-u.ac.jp
Affiliations Toho University Ohashi Medical Center, Department of Diabetes and Metabolism, Tokyo, Japan, Mitsui Memorial Hospital, Division of Diabetes and Metabolism, Tokyo Japan
- RESEARCH Study Group
-
¶Membership of the RESEARCH Study Group are stated in the paper of Ref. 16.
Competing Interests
Teruo Shiba has received honoraria from Shionogi & Co., Ltd., Pfizer Japan Inc., Merck Sharp & Dohme (MSD), Kowa Company, Ltd., and Daiichi Sankyo Company Limited. Tsutomu Yamazaki has received research support and honoraria from Merck Sharp & Dohme (MSD), Pfizer Japan Inc., Kowa Company, Ltd., Shionogi & Co., Ltd., and AstraZeneca K.K., and honoraria from Bayer Holding Ltd. and Daiichi Sankyo Company Limited. Akira Tanaka has received research support from Daiichi Sankyo Company Limited and honoraria from Merck Sharp & Dohme (MSD), and Kewpie Corporation. Takahide Kohro has received research support from AstraZeneca K.K. and honoraria from Merck Sharp & Dohme (MSD). The other authors have no conflicts of interest to declare. This does not alter the authors' adherence to PLOS ONE policies on the sharing of data and materials.
Author Contributions
Conceived and designed the experiments: MK M. Tagami AT YM TS. Performed the experiments: KS MK MO TW KA T. Horiuchi HH NS RC M. Tsujino T. Hiyoshi M. Tagami AT YM TI T. Hirano TS. Analyzed the data: TK TY. Contributed reagents/materials/analysis tools: T. Hirano. Wrote the paper: KS TS. sd-LDL measurement: T. Hirano.